ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,424.80
      0.12%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.785
      1.05%
      Bitcoin
      65,082.10
      -2.11%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      12/08/202112:25PMTipRanksNeedham Thinks Esperion’s Stock is Going to RecoverNASDAQ:ESPREsperion Therapeutics Inc
      12/07/20215:19PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      12/07/20214:05PMGlobeNewswire Inc.Esperion Announces Closing of $225 Million Public OfferingNASDAQ:ESPREsperion Therapeutics Inc
      12/07/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      12/06/20214:38PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ESPREsperion Therapeutics Inc
      12/02/202111:40PMGlobeNewswire Inc.Esperion Announces Pricing of $225 Million Public OfferingNASDAQ:ESPREsperion Therapeutics Inc
      12/02/20215:00PMGlobeNewswire Inc.Esperion Announces Proposed Public OfferingNASDAQ:ESPREsperion Therapeutics Inc
      11/12/20217:00AMGlobeNewswire Inc.Esperion Presents Important New Science Highlighting Potential Benefits of NEXLETOL® (bempedoic acid) Tablets at American Heart Association Scientific Sessions 2021NASDAQ:ESPREsperion Therapeutics Inc
      11/02/20219:05AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      11/02/20217:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/02/20217:00AMGlobeNewswire Inc.Esperion Reports Third Quarter 2021 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      11/01/20214:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20214:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20214:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20214:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20214:01PMGlobeNewswire Inc.Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20217:00AMGlobeNewswire Inc.Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of DirectorsNASDAQ:ESPREsperion Therapeutics Inc
      10/27/20214:01PMGlobeNewswire Inc.Esperion to Participate in Upcoming Virtual Investor ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      10/25/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      10/25/20217:00AMGlobeNewswire Inc.ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common StockNASDAQ:ESPREsperion Therapeutics Inc
      10/18/20219:28AMTipRanksEsperion Plans Expense & Operational Structure Alignment; Shares Fall 1.5% Pre-MarketNASDAQ:ESPREsperion Therapeutics Inc
      10/18/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      10/18/20217:00AMGlobeNewswire Inc.ESPERION Announces Plan for Transformative Long-Term GrowthNASDAQ:ESPREsperion Therapeutics Inc
      10/12/20218:00AMGlobeNewswire Inc.Esperion to Report Third Quarter 2021 Financial Results November 2, 2021NASDAQ:ESPREsperion Therapeutics Inc
      09/07/20214:01PMGlobeNewswire Inc.ESPERION to Host Investor Webinar on the Current Landscape and Future Directions in the Treatment of Elevated CholesterolNASDAQ:ESPREsperion Therapeutics Inc
      08/26/20218:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming Virtual Investor ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      08/03/202111:06AMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ESPREsperion Therapeutics Inc
      08/03/202111:05AMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ESPREsperion Therapeutics Inc
      08/03/20219:27AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR